Suppr超能文献

抑制MicroRNA-494可减少颈动脉粥样硬化病变发展并增加斑块稳定性。

Inhibition of MicroRNA-494 Reduces Carotid Artery Atherosclerotic Lesion Development and Increases Plaque Stability.

作者信息

Wezel Anouk, Welten Sabine M J, Razawy Wida, Lagraauw H Maxime, de Vries Margreet R, Goossens Eveline A C, Boonstra Martin C, Hamming Jaap F, Kandimalla Ekambar R, Kuiper Johan, Quax Paul H A, Nossent A Yaël, Bot Ilze

机构信息

*Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands †Division of Biopharmaceutics, LACDR, Leiden University, Leiden, The Netherlands ‡Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands §Idera Pharmaceuticals, Cambridge, MA.

出版信息

Ann Surg. 2015 Nov;262(5):841-7; discussion 847-8. doi: 10.1097/SLA.0000000000001466.

Abstract

OBJECTIVES

Unstable atherosclerotic lesions in carotid arteries require surgical endarterectomy to reduce the risk of ischemic stroke. We aimed to identify microRNAs that exert a broad effect on atherosclerotic plaque formation and stability in the carotid artery.

BACKGROUND

We made a selection of 164 genes involved in atherosclerosis. Using www.targetscan.org, we determined which microRNAs potentially regulate expression of these genes. We identified multiple microRNAs from the 14q32 microRNA cluster, which is highly involved in vascular remodeling. In human plaques, collected during carotid endarterectomy surgery, we found that 14q32 microRNA (miR-494) was abundantly expressed in unstable lesions.

METHODS

We induced atherosclerotic plaque formation in hypercholesterolemic ApoE mice by placing semiconstrictive collars around both carotid arteries. We injected "Gene Silencing Oligonucleotides" against miR-494 (GSO-494) or negative control (GSO-control). Using fluorescently labeled GSOs, we confirmed uptake of GSOs in affected areas of the carotids, but not elsewhere in the vasculature.

RESULTS

After injection of GSO-494, we observed significant downregulation of miR-494 expression in the carotid arteries, although miR-494 target genes were upregulated. Further analyses revealed a 65% decrease in plaque size after GSO-494 treatment. Plaque stability was increased in GSO-494-treated mice, determined by an 80% decrease in necrotic core size and a 50% increase in plaque collagen content. Inhibition of miR-494 also resulted in decreased cholesterol levels and decreased very low-density lipoprotein (VLDL) fractions.

CONCLUSIONS

Treatment with GSO-494 results in smaller atherosclerotic lesions with increased plaque stability. Inhibition of miR-494 may decrease the risk of surgical complications or even avert endarterectomy surgery in some cases.

摘要

目的

颈动脉不稳定动脉粥样硬化病变需要进行外科动脉内膜切除术以降低缺血性中风风险。我们旨在识别对颈动脉粥样硬化斑块形成和稳定性具有广泛影响的微小RNA。

背景

我们挑选了164个参与动脉粥样硬化的基因。利用www.targetscan.org,我们确定了哪些微小RNA可能调节这些基因的表达。我们从高度参与血管重塑的14q32微小RNA簇中鉴定出多个微小RNA。在颈动脉内膜切除术期间收集的人类斑块中,我们发现14q32微小RNA(miR-494)在不稳定病变中大量表达。

方法

我们通过在双侧颈动脉周围放置半缩窄套环,在高胆固醇血症ApoE小鼠中诱导动脉粥样硬化斑块形成。我们注射针对miR-494的“基因沉默寡核苷酸”(GSO-494)或阴性对照(GSO-对照)。使用荧光标记的GSO,我们证实GSO在颈动脉的受影响区域被摄取,但在脉管系统的其他部位未被摄取。

结果

注射GSO-494后,我们观察到颈动脉中miR-494表达显著下调,尽管miR-494靶基因上调。进一步分析显示,GSO-494治疗后斑块大小减少了65%。通过坏死核心大小减少80%和斑块胶原含量增加50%确定,GSO-494治疗的小鼠斑块稳定性增加。抑制miR-494还导致胆固醇水平降低和极低密度脂蛋白(VLDL)组分减少。

结论

GSO-494治疗可导致动脉粥样硬化病变更小且斑块稳定性增加。抑制miR-494可能降低手术并发症风险,甚至在某些情况下避免动脉内膜切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验